| # | Title | Journal | Year | Citations |
|---|
| 1 | The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years | Movement Disorders | 2008 | 1,779 |
| 2 | Phenomenology and classification of dystonia: A consensus update | Movement Disorders | 2013 | 1,754 |
| 3 | Sydney multicenter study of Parkinson's disease: Non‐ L ‐dopa–responsive problems dominate at 15 years | Movement Disorders | 2005 | 967 |
| 4 | Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1 | Nature Genetics | 2013 | 589 |
| 5 | A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease | Movement Disorders | 2010 | 467 |
| 6 | Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination | Journal of Neurology, Neurosurgery and Psychiatry | 2018 | 422 |
| 7 | The progression of pathology in longitudinally followed patients with Parkinson’s disease | Acta Neuropathologica | 2008 | 337 |
| 8 | Sodium-channel defects in benign familial neonatal-infantile seizures | Lancet, The | 2002 | 332 |
| 9 | Clinical and physiological assessments for elucidating falls risk in Parkinson's disease | Movement Disorders | 2009 | 316 |
| 10 | The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years | Journal of Neurology, Neurosurgery and Psychiatry | 1999 | 309 |
| 11 | Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis | Multiple Sclerosis Journal | 2016 | 284 |
| 12 | A proposal for new diagnostic criteria for ALS | Clinical Neurophysiology | 2020 | 268 |
| 13 | The distribution of structural neuropathology in pre-clinical Huntington's disease | Brain | 2002 | 247 |
| 14 | Regional Specificity of Brain Atrophy in Huntington's Disease | Experimental Neurology | 1998 | 224 |
| 15 | Decomposing skin conductance into tonic and phasic components | International Journal of Psychophysiology | 1997 | 185 |
| 16 | A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Phase III Study to Investigate Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND) | International Journal of Stroke | 2012 | 182 |
| 17 | Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study | Frontiers in Aging Neuroscience | 2014 | 177 |
| 18 | Postural Instability in Patients with Parkinson’s Disease | CNS Drugs | 2013 | 168 |
| 19 | Three simple clinical tests to accurately predict falls in people with Parkinson's disease | Movement Disorders | 2013 | 167 |
| 20 | Walking speed, cadence and step length are selected to optimize the stability of head and pelvis accelerations | Experimental Brain Research | 2007 | 166 |
| 21 | Huntington’s disease | Neurology | 2003 | 165 |
| 22 | Emerging therapies and challenges in spinal muscular atrophy | Annals of Neurology | 2017 | 157 |
| 23 | Myoclonus-dystonia: significance of largeSGCEdeletions | Human Mutation | 2008 | 138 |
| 24 | Impact of the COVID‐19 Pandemic on Parkinson's Disease and Movement Disorders | Movement Disorders | 2020 | 134 |
| 25 | Voxel‐based morphometric magnetic resonance imaging (MRI) postprocessing in MRI‐negative epilepsies | Annals of Neurology | 2015 | 128 |
| 26 | Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy | Brain | 2002 | 126 |
| 27 | Acceleration Patterns of the Head and Pelvis During Gait in Older People With Parkinson's Disease: A Comparison of Fallers and Nonfallers | Journals of Gerontology - Series A Biological Sciences and Medical Sciences | 2009 | 125 |
| 28 | Regional brain atrophy in progressive supranuclear palsy and Lewy body disease | Annals of Neurology | 2000 | 116 |
| 29 | Treatment of idiopathic spasmodic torticollis with botulinum toxin a: A double-blind study on twenty-three patients | Movement Disorders | 1991 | 115 |
| 30 | The distinctive movement disorder of ovarian teratoma‐associated encephalitis | Movement Disorders | 2008 | 115 |
| 31 | A novel cause of chronic viral meningoencephalitis: Cache Valley virus | Annals of Neurology | 2017 | 111 |
| 32 | Incidence and prevalence of NMOSD in Australia and New Zealand | Journal of Neurology, Neurosurgery and Psychiatry | 2017 | 108 |
| 33 | A video review of the diagnosis of psychogenic gait: Appendix and commentary | Movement Disorders | 1999 | 107 |
| 34 | Phenotypic insights into ADCY5 ‐associated disease | Movement Disorders | 2016 | 106 |
| 35 | Pathogenic effects of novel mutations in the P‐type ATPase ATP13A2 ( PARK9 ) causing Kufor‐Rakeb syndrome, a form of early‐onset parkinsonism | Human Mutation | 2011 | 105 |
| 36 | Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy | Journal of Pediatrics | 2013 | 104 |
| 37 | Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy | Neuromuscular Disorders | 2010 | 100 |
| 38 | Fatigue in multiple sclerosis: Mechanisms and management | Clinical Neurophysiology | 2010 | 97 |
| 39 | Split-hand index for the diagnosis of amyotrophic lateral sclerosis | Clinical Neurophysiology | 2013 | 97 |
| 40 | DIABETIC NEUROPATHY AFTER PANCREAS TRANSPLANTATION: DETERMINANTS OF RECOVERY | Transplantation | 1997 | 97 |
| 41 | Movement disorder emergencies | Movement Disorders | 2005 | 96 |
| 42 | Memory and phonological awareness in children with Benign Rolandic Epilepsy compared to a matched control group | Epilepsy Research | 2007 | 94 |
| 43 | Neuropsychological abnormalities in patients with pituitary tumours | Acta Neurologica Scandinavica | 1992 | 91 |
| 44 | Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease | Movement Disorders | 2002 | 91 |
| 45 | The current use of botulinum toxin | Journal of Clinical Neuroscience | 2000 | 90 |
| 46 | Pathophysiological insights into ALS with C9ORF72 expansions | Journal of Neurology, Neurosurgery and Psychiatry | 2013 | 89 |
| 47 | Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancy | Movement Disorders | 2002 | 88 |
| 48 | Assessment of patients with isolated or combined dystonia: An update on dystonia syndromes | Movement Disorders | 2013 | 88 |
| 49 | Huntingtonʼs disease | Current Opinion in Neurology | 2012 | 87 |
| 50 | Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement | European Journal of Neurology | 2010 | 86 |
